A major nidogen binding site of mouse laminin was previously localized
to about three EGF-like repeats (Nos 3-5) of its B2 chain domain III
[M.Gerl et al. (1991) Eur. J. Biochem., 202, 167]. The corresponding c
DNA was amplified by polymerase chain reaction and inserted into a euk
aryotic expression vector tagged with a signal peptide. Stably transfe
cted human kidney cell clones were shown to process and secrete the re
sulting fragment B2III3-5 in substantial quantities. It possessed high
binding activity for recombinant nidogen in ligand assays, with an af
finity comparable with that of authentic laminin fragments. In additio
n, complexes of B2III3-5 and nidogen could be efficiently converted in
to a covalent complex by cross-linking reagents. Proteolytic degradati
on of the covalent complex demonstrated the association of B2III3-5 wi
th a approximately 80 residue segment of nidogen domain G3 to which la
minin binding has previously been attributed. The correct formation of
most of the 12 disulfide bridges in B2III3-5 was indicated from its p
rotease resistance and the complete loss of cross-reacting epitopes as
well as of nidogen-binding activity after reduction and alkylation. S
maller fragments were prepared by the same recombinant procedure and s
howed that combinations of EGF-like repeats 3-4 and 4-5 and the single
repeat 4 but not repeats 3 or 5 possess full nidogen-binding activity
. This identifies repeat 4 as the only binding structure. The sequence
of repeat 4 is well conserved in the human and in part in the Drosoph
ila laminin B2 chain. It was further shown that antibodies against B2I
II3-5 inhibit laminin binding to nidogen, indicating that repeat 4 rep
resents the only high affinity binding site of laminin.